Inovio to participate in the h.c. wainwright 27th annual global investment conference

Plymouth meeting, pa. , aug. 25, 2025 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-associated diseases, cancer and infectious diseases, today announced that a pre-recorded presentation from the company will be available on demand as a part of the h.c.

INO Ratings Summary

INO Quant Ranking